Treatment of Xeroderma Pigmentosum with Central and Peripheral Nervous System Abnormalities (XP/CS Complex)

Clinical Scenario

Xeroderma pigmentosum complicated by abnormalities of the central and peripheral nervous systems — including psychomotor changes and XP/CS (Cockayne syndrome) complex — is a clinically distinct presentation in which neurological involvement substantially shapes the management approach and prognosis.

In a significant proportion of XP patients, the condition is complicated by central and peripheral nervous system abnormalities. Psychomotor changes and their rate of progression are among the principal factors that influence prognosis. When XP/CS complex is confirmed, the framework for XP neurological disease management applies.

Treatment Approach

For specific neuromuscular complications that arise as neurological disease progresses — particularly when management of the patient becomes increasingly difficult — a targeted intervention involving a neurotoxin-based agent may be considered. The complete structured regimen and all clinical decision points are available in the full protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/1346-8138.13907

In the majority of Japanese patients, XP is complicated with abnormalities in the central and peripheral nervous systems, such as psychomotor retardations of which progression and severity greatly influence the prognosis.

If the patient is diagnosed with XP/CS complex, conform to the guidelines for XP neurological disease.

If muscle tonus of the upper and lower extremities is worsened and nursing seems to be hard, treatment with botulinum toxin might be considered.

View source ↗